Ad
Wednesday, 27 May 2020
Roche to study remdesivir/Actemra cocktail against severe COVID-19 pneumonia
Swiss drugmaker Roche said on Thursday it would study its anti-inflammation drug Actemra mixed with Gilead Sciences Inc's remdesivir in hospitalised patients with severe COVID-19 pneumonia in a global trial of around 450 patients.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment